Xu, J., Li, Z., Tong, Q., Zhang, S., Fang, J., Wu, A., Wei, G., Zhang, C., Yu, S., Zheng, B., Lin, H., Liao, X., Xiao, Z., Lu, W. (2025). CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma. Nature Communications. https://doi.org/10.1038/s41467-025-55876-0